Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immunization”

929 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 929 results

Not applicableStudy completedNCT01296906
What this trial is testing

Population Versus Practice-based Interventions to Increase Immunizations

Who this might be right for
Health Services ResearchComparative EffectivenessImmunization
University of Colorado, Denver 31,567
Not applicableStudy completedNCT02443233
What this trial is testing

Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong

Who this might be right for
Hepatitis B Infection
The University of Hong Kong 750
Post-approval studies (Phase 4)Active Not RecruitingNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Not applicableStudy completedNCT03428776
What this trial is testing

Timeliness of Immunization and Compliance Assessment Study

Who this might be right for
Vaccinations
Johns Hopkins University 2,065
Large-scale testing (Phase 3)UnknownNCT05969626
What this trial is testing

Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)

Who this might be right for
Rabies
Ningbo Rongan Biological Pharmaceutical Co., Ltd. 2,460
Testing effectiveness (Phase 2)Study completedNCT00006385
What this trial is testing

Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT02757950
What this trial is testing

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

Who this might be right for
Diphtheria
GlaxoSmithKline 2,462
Large-scale testing (Phase 3)WithdrawnNCT01676948
What this trial is testing

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT03947138
What this trial is testing

GC3107(BCG Vaccine) in Healthy Infants

Who this might be right for
BCG Vaccination ReactionTuberculosis
Green Cross Corporation 750
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Not applicableStudy completedNCT04918940
What this trial is testing

Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Follicular LymphomaMantle Cell Lymphoma
Centre Henri Becquerel 20
Not applicableStudy completedNCT01770496
What this trial is testing

Age-Specific Strategies for Immunization Reminders and Recalls

Who this might be right for
Childhood Vaccination
University of Michigan 10,175
Not applicableStudy completedNCT02479659
What this trial is testing

Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services

Who this might be right for
HIV
IDinsight 60
Large-scale testing (Phase 3)Study completedNCT01953510
What this trial is testing

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam

Who this might be right for
Pneumococcal Vaccines
Murdoch Childrens Research Institute 1,400
Post-approval studies (Phase 4)Study completedNCT03489018
What this trial is testing

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Who this might be right for
Pneumococcal InfectionStreptococcus Pneumoniae InfectionInvasive Pneumococcal Disease, Protection Against
London School of Hygiene and Tropical Medicine 2,100
Early research (Phase 1)Study completedNCT00000642
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT02904642
What this trial is testing

Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial

Who this might be right for
Measles
Johns Hopkins Bloomberg School of Public Health 537
Early research (Phase 1)Not Yet RecruitingNCT07406347
What this trial is testing

A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 60
Load More Results